React to CRVS News, Headlines, and Press Releases.

SpeculatingStocks.com > News Headlines > CRVS News Headlines Related to Corvus Pharmaceuticals

Join in on the discussion at SpeculatingStocks surrounding Corvus Pharmaceuticals (CRVS) news headlines. No login required, react anonymously to Corvus Pharmaceuticals news headlines.

Latest News on Corvus Pharmaceuticals (CRVS) from around the Web and from the Company

📰 Wed, Aug 5, 2020 at 1:50 AM EST:

$CRVS (Corvus Pharmaceuticals) Headline: Corvus Pharmaceuticals to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference

💬 View Reactions / React Anonymously


📰 Wed, Feb 6, 2019 at 4:07 PM EST:

$CRVS (Corvus Pharmaceuticals) Headline: Corvus Presents Updated Biomarker and Clinical Results from Lead Pipeline Programs CPI-444 and CPI-006 at Immuno-Oncolog...

💬 View Reactions / React Anonymously



📰 Fri, Feb 23, 2018 at 8:13 PM EST:

$CRVS (Corvus Pharmaceuticals) Headline: Corvus Pharmaceuticals Announces Presentation of New Data from Preclinical Study of Novel T-Cell Signaling Pathway Inhib...

💬 View Reactions / React Anonymously


📰 Thu, Feb 22, 2018 at 10:21 PM EST:

$CRVS (Corvus Pharmaceuticals) Headline: Corvus Pharmaceuticals Announces Presentation of New Data from Preclinical Study of Novel T-Cell Signaling Pathway Inhib...

💬 View Reactions / React Anonymously


📰 Fri, Feb 9, 2018 at 8:49 PM EST:

$CRVS (Corvus Pharmaceuticals) Headline: Corvus Pharmaceuticals Announces Presentation of New Data from Preclinical Study of Novel T-Cell Signaling Pathway Inhib...

💬 View Reactions / React Anonymously


📰 Fri, Jan 5, 2018 at 6:35 PM EST:

$CRVS (Corvus Pharmaceuticals) Headline: Corvus Pharmaceuticals Announces Updated Clinical Data from Phase 1/1b Study of CPI-444 and Biomarker Data for Potential...

💬 View Reactions / React Anonymously



📰 Mon, Nov 13, 2017 at 9:36 PM EST:

$CRVS (Corvus Pharmaceuticals) Headline: Corvus Pharmaceuticals Announces Updated Clinical Data from Phase 1/1b Study of CPI-444 and Biomarker Data for Potential... -- View on Google

💬 View Reactions / React Anonymously


📰 Sat, Nov 4, 2017 at 8:56 PM EST:

$CRVS (Corvus Pharmaceuticals) Headline: Corvus Pharmaceuticals Reports Third Quarter 2017 Financial Results and Clinical Program Update -- View on Google

💬 View Reactions / React Anonymously


📰 Sat, Oct 14, 2017 at 12:41 AM EST:

$CRVS (Corvus Pharmaceuticals) Headline: Corvus Pharmaceuticals to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference -- View on Google

💬 View Reactions / React Anonymously


📰 Wed, Jan 25, 2017 at 1:28 AM EST:

$CRVS Headline: Corvus Pharmaceuticals Announces Expansion of Renal Cell Carcinoma Cohort in Ongoing Phase 1/1b Clinical Study of Lead C...

💬 View Reactions / React Anonymously


📰 Sat, Aug 20, 2016 at 5:19 AM EST:

$CRVS Headline: Corvus reports 2Q loss

💬 View Reactions / React Anonymously



📰 Fri, Jun 17, 2016 at 3:41 PM EST:

$CRVS Headline: Corvus Pharmaceuticals’ Ian McCaffery, PhD to Present at Rational Combinations 360° June 23-24, New York

💬 View Reactions / React Anonymously


📰 Tue, May 17, 2016 at 12:30 AM EST:

$CRVS Headline: CORVUS PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements

💬 View Reactions / React Anonymously


📰 Mon, May 16, 2016 at 10:03 PM EST:

$CRVS Headline: CORVUS PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements

💬 View Reactions / React Anonymously


📰 Thu, Apr 7, 2016 at 10:54 AM EST:

$CRVS Headline: Corvus Pharmaceuticals to Present at AACR Annual Meeting April 16 – 20 in New Orleans

💬 View Reactions / React Anonymously


📰 Tue, Apr 5, 2016 at 2:46 PM EST:

$CRVS Headline: Corvus Pharmaceuticals to Present at AACR Annual Meeting April 16 – 20 in New Orleans

💬 View Reactions / React Anonymously



📰 Sun, Apr 3, 2016 at 2:13 PM EST:

$CRVS Headline: [$$] IPOs: The Worst Yearly Start Since the Recession

💬 View Reactions / React Anonymously


📰 Thu, Mar 31, 2016 at 12:18 PM EST:

$CRVS Headline: [$$] ImmuneXcite Collects $8.6M for Immuno-Oncology Therapies

💬 View Reactions / React Anonymously


📰 Mon, Mar 28, 2016 at 11:29 AM EST:

$CRVS Headline: First Quarter IPOs Worst Since 2009

💬 View Reactions / React Anonymously